ARCHIVE

• Zoledronate Delays Onset of Cancer-related Bone Complications: Novartis
  June 17, 2002

• Meiji Seika Kaisha: Drug Sales Down 6.1% to \110.7 Bil.
  June 17, 2002

• Speed, Quality, Costs Are Main Problems for Clinical Trials in Japan
  June 17, 2002

• Effects of Glivec on GIST Presented
  June 17, 2002

• Kirin: 1st Qtr Drug Sales Up 4.9% to \9.2 Bil.
  June 17, 2002

• Tokyo Area Genomic Network Promotion Council Inaugurated
  June 17, 2002

• Pharmacia Reports PIII Results on Eplerenone
  June 17, 2002

• CORPORATE ROUNDUP NEWS IN BRIEF
  June 17, 2002

• PRESS SEMINARS
  June 17, 2002

• Gemcitabine, Carboplatin Combination Useful for NSCLC: ASCO
  June 17, 2002

• Mr Wager of Aventis Behring Points Out Problems with Proposed Blood Law
  June 17, 2002

• RESEARCH AND DEVELOPMENT NEWS IN BRIEF
  June 17, 2002

• Preventive Effects of Evista on Bone Fractures in Osteoporosis Reported
  June 17, 2002

• We Are at Exciting Crossroads in History: Mr Hassan at PhRMA
  June 17, 2002

• Matsumotokiyoshi: Record-high Sales of \256 Bil., Profits of \6.6 Bil. Posted
  June 17, 2002

• Eli Lilly's Teriparatide Effective against Severe Osteoporosis
  June 17, 2002

• 94 Drugs in Development for Children: PhRMA Survey
  June 17, 2002

• BULLETIN
  June 17, 2002

• Ohki: Consolidated Sales Increase by 4.1% to \69.7 Bil.
  June 17, 2002

• Clinical Trial Results for Eli Lilly's New ED Drug Reported
  June 17, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 671
• 672
• 673
• 674
• 675
• 676
• 677
• 678
• 679
• …
• Next ›
• 最終 »